Radiopharm Theranostics (RADX) Equity Ratio (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Equity Ratio for 2 consecutive years, with 0.5 as the latest value for Q2 2025.
- Quarterly Equity Ratio rose 30.55% to 0.5 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 0.5 through Jun 2025, up 30.55% year-over-year, with the annual reading at 0.5 for FY2025, 30.55% up from the prior year.
- Equity Ratio for Q2 2025 was 0.5 at Radiopharm Theranostics, up from 0.38 in the prior quarter.
- The five-year high for Equity Ratio was 0.5 in Q2 2025, with the low at 0.38 in Q2 2024.